Dental Times

clinical

Theradaptive Completes Enrollment in RESTORE Study

Study enrollment completion marks critical milestone in advancing bone regeneration for dental reconstruction using Theradaptive’s targeted therapeutic platform Theradaptive, Inc., a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, recently announced the successful treatment of the 45th and final patient in the RESTORE International Phase I/II Feasibility Study. This prospective, blinded, randomized, controlled […] The post Theradaptive Completes Enrollment in RESTORE Study appeared first on Dentistry Today.

By Dentistry Today ·

Study enrollment completion marks critical milestone in advancing bone regeneration for dental reconstruction using Theradaptive’s targeted therapeutic platform Theradaptive, Inc., a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, recently announced the successful treatment of the 45th and final patient in the RESTORE International Phase I/II Feasibility Study. This prospective, blinded, randomized, controlled […]

The post Theradaptive Completes Enrollment in RESTORE Study appeared first on Dentistry Today.

Read the original reporting at Dentistry Today